The overuse of antimicrobial agents in medical and veterinary applications has led to the development of antimicrobial resistance in some microorganisms and this is now one of the major concerns in modern society. In this context, the use of transition metal complexes with photoactivatable properties, which can act as drug delivery systems triggered by light, could become a potent strategy to overcome the problem of resistance. In this work several Ru complexes with terpyridine ligands and the clotrimazole fragment, which is a potent antimycotic drug, were synthesized. The main goal was to explore the potential photoactivated activity of the complexes as antifungal agents and evaluate the effect of introducing different substituents on the terpyridine ligand. The complexes were capable of delivering the clotrimazole unit upon irradiation with visible light in a short period of time. The influence of the substituents on the photodissociation rate was explained by means of TD-DFT calculations. The complexes were tested against three different yeasts, which were selected based on their prevalence in fungal infections. The complex in which a carboxybenzene unit was attached to the terpyridine ligand showed the best activity against the three species under light, with minimal inhibitory concentration values of 0.88 μM and a phototoxicity index of 50 achieved. The activity of this complex was markedly higher than that of free clotrimazole, especially upon irradiation with visible light (141 times higher). The complexes were more active on yeast species than on cancer cell lines
Article
Published version
peer-reviewed
English
Ruteni -- Compostos; Ruthenium compounds; Medicaments antifúngics; Antifungal agents; Microorganismes -- Resistència als medicaments; Drug resistance in microorganisms
Elsevier
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jinorgbio.2024.112692
info:eu-repo/semantics/altIdentifier/issn/0162-0134
info:eu-repo/semantics/altIdentifier/eissn/1873-3344
Reconeixement 4.0 Internacional